Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China
Pingjin Gao(Shanghai Institute of Hypertension), Yu Xiaowei(Shaoxing People's Hospital), Licheng Yu(Beijing Haidian Hospital), Hong Ding(Xian Yang Central Hospital), Ming Yang(Beijing Tongren Hospital), Hua You(Soochow University), Mei Kezhi, Ke shi Lu(Suzhou Municipal Hospital), Hongwei Li(Chang'an University), Xiaoling Peng(Apple (Israel)), Zhimin Jin(Songjiang District Central Hospital), Shuxian Zhou(Shandong University of Technology), Qi Hua(Capital Medical University), Qiuyan Dai(Shanghai First People's Hospital), Pengfei Yin(Capital Medical University), Xingui Guo(Fudan University), Hui Xu(The University of Texas MD Anderson Cancer Center), Lin Pi(Beijing Chuiyangliu Hospital)
Cited by 4
Related Papers
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
|Journal of Hematology & Oncology|2021|129
The landscape overview of CD47-based immunotherapy for hematological malignancies
|Biomarker Research|2023|119
Highly improved ethanol gas response of n-type α-Fe2O3 bunched nanowires sensor with high-valence donor-doping
|Journal of Alloys and Compounds|2020|92
The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats
|International Journal of Molecular Medicine|2014|85
Oxidative stress mediates chemerin-induced autophagy in endothelial cells
|Free Radical Biology and Medicine|2012|84